10 Best Psychedelic Therapy Clinics in Los Angeles, California (2026)

What does this directory page list?

This page lists directory records associated with Psychedelic Therapy in the Los Angeles, California browsing area. A browsing area can include nearby municipalities. Confirm each clinic's street address and current services directly.

Matching records:

10. Source: the current directory result set, including pages beyond this screen.

Treatment filter:

Psychedelic Therapy.

Source limits:

Listing information is not an independent clinic evaluation. Record updates do not establish field-level check dates.

Read the Psychedelic Therapy guide for the educational context behind this treatment category.

Psychedelic Therapy clinics in Los Angeles

Los Angeles has 7 providers offering psychedelic therapy, with ketamine-assisted psychotherapy as the dominant nationwide option. Ketamine is FDA-approved as an anesthetic and Spravato (esketamine) is FDA-approved for treatment-resistant depression, while ketamine-assisted psychotherapy (KAP) is practiced off-label by licensed clinicians. In California, ketamine-assisted psychotherapy is the only medically available psychedelic option. Psilocybin and MDMA remain Schedule I federally. Psilocybin is legal only in Oregon and Colorado under state programs. MDMA-assisted therapy was not approved by the FDA in August 2024 after a Complete Response Letter to Lykos Therapeutics. Los Angeles clinics commonly pair ketamine infusions or IM injections with therapy sessions, typical packages run 2,500 to 6,000 dollars for a six-session protocol, and Spravato is covered by many insurers when criteria are met. Psilocybin and MDMA remain federally illegal, and the FDA issued a Complete Response Letter to Lykos Therapeutics in August 2024 for MDMA-assisted therapy for PTSD. A reputable Los Angeles provider will screen for cardiovascular risk, psychiatric history, and concurrent medications before starting treatment.

A note on California's psychedelic therapy rules.

Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.

SB 803 (2023, vetoed) and SB 1012 (2024, stalled)
Proposed regulated therapeutic access to psilocybin, MDMA, mescaline, and DMT; Governor Newsom vetoed SB 58 (2023) citing lack of treatment guidelines.
Local decriminalization resolutions
Oakland (2019), Santa Cruz (2020), Arcata, San Francisco, and Berkeley have passed non-binding resolutions deprioritizing enforcement of natural psychedelics; no legal therapeutic framework.

California enforces federal DEA scheduling. The Medical Board of California investigates prescriber misconduct, including ketamine diversion and inadequate patient monitoring. Several high-profile California ketamine-related deaths (including Matthew Perry's 2023 overdose) have intensified board scrutiny of clinic practices. DEA enforcement targets compounding, diversion, and Ryan Haight Act telehealth compliance.

Psychedelic Therapy in Los Angeles, answered.

In California, ketamine-assisted psychotherapy is the primary legal option. Ketamine is a Schedule III controlled substance prescribed off label for depression, anxiety, and PTSD. Psilocybin and MDMA are Schedule I federally and not legally available in California. Only Oregon (Measure 109) and Colorado (Proposition 122) currently operate regulated psilocybin programs.

In Los Angeles, ketamine-assisted psychotherapy typically runs 400 to 900 dollars per session, with full protocols of six sessions costing 2,500 to 6,000 dollars. IM injection sessions tend to be less expensive than IV infusions. Spravato (esketamine nasal spray) is FDA-approved for treatment-resistant depression and may be covered by insurance with prior authorization, though out-of-pocket copays vary. Integration therapy sessions are often billed separately at 150 to 300 dollars each.

Not as an FDA-approved treatment. In August 2024 the FDA issued a Complete Response Letter to Lykos Therapeutics (formerly MAPS PBC) for MDMA-assisted therapy for PTSD, citing concerns about trial design and data quality. MDMA remains Schedule I federally. Some expanded access and clinical trial pathways exist, but no Los Angeles clinic can legally prescribe MDMA outside of those frameworks. Lykos has stated it plans to resubmit following additional trial work.

Ketamine-assisted psychotherapy is used off-label for treatment-resistant depression, PTSD, anxiety, and suicidal ideation. Spravato (esketamine) carries FDA approval specifically for treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior. Evidence quality is strongest for depression, with multiple randomized trials supporting short-term benefit. Los Angeles clinics typically screen for cardiovascular conditions, psychotic disorders, and active substance use before starting treatment.

Verify the prescriber on the California medical board license lookup and NPI registry. Confirm the clinician has training in psychedelic-assisted therapy through MAPS, Fluence, Polaris, or a comparable program. Ask about screening protocols, emergency procedures, and whether a therapist is present during sessions. Check the FDA warning letter database. Avoid clinics promising guaranteed outcomes, pushing large prepaid packages, or operating outside of state licensure. Integration support should be part of any reputable protocol.

10 Best Psychedelic Therapy Clinics in Los Angeles, California

Compare clinic listings by treatment and location. A listing is not a medical endorsement. Organic rank is never for sale; Featured placements are labeled and separate from organic results.

What does this directory page list?

Psychedelic Therapy clinics in Los Angeles

10 Clinics

Wave Psychiatric Group

Clear Mind Treatment

Felicity Mental Health Ketamine Therapy - Century City

Bio-identical Hormone Replacement Therapy & Weight Loss

Cole Marta, MD - Psychiatrist

Enhanced Mindful Therapy

Psychiatry Treatment Centers

Better U

Felicity Mental Health

TRIP Clinic Hollywood

A note on California's psychedelic therapy rules.

Psychedelic Therapy in Los Angeles, answered.

Psychedelic Therapy in nearby Cities

Other Treatments available in Los Angeles

10 Best Psychedelic Therapy Clinics in Los Angeles, California

Compare clinic listings by treatment and location. A listing is not a medical endorsement. Organic rank is never for sale; Featured placements are labeled and separate from organic results.

What does this directory page list?

Psychedelic Therapy clinics in Los Angeles

10 Clinics

A note on California's psychedelic therapy rules.

Psychedelic Therapy in Los Angeles, answered.

What psychedelic therapies are legally available in Los Angeles?

How much does ketamine-assisted psychotherapy cost in Los Angeles?

Is MDMA-assisted therapy available?

What conditions does ketamine-assisted therapy treat?

How do I choose a reputable psychedelic therapy clinic in Los Angeles?

Psychedelic Therapy in nearby Cities

Other Treatments available in Los Angeles